The Chemours Company
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $3.72B | $1.08B | $1.45B |
| FY2022 | $3.59B | $1.11B | $1.10B |
| FY2023 | $3.99B | $749.0M | $1.20B |
| FY2024 | $4.06B | $571.0M | $713.0M |
| FY2025 | $4.07B | $566.0M | $670.0M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $3.72B | $1.08B | $1.45B |
| FY2022 | $3.59B | $1.11B | $1.10B |
| FY2023 | $3.99B | $749.0M | $1.20B |
| FY2024 | $4.06B | $571.0M | $713.0M |
| FY2025 | $4.07B | $566.0M | $670.0M |